Alexandraki Krystallenia I, Violetis Odysseas, Memi Eleni, Fryssira Helen, Papanikolaou Vasileios, Papagianni Maria, Mastorakos George
2nd Department of Surgery, Aretaieio Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Unit of Endocrinology, Diabetes mellitus, and Metabolism, Aretaieion Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Endocrine. 2025 May 28. doi: 10.1007/s12020-025-04261-4.
To report a case with combined pituitary hormone deficiency (CPHD) and Fibroblast growth factor receptor 1 (FGFR1) gene defect, and summarize the clinical characteristics of similar cases by reviewing the current reports from the literature.
A 24-year-old woman was admitted to the outpatient endocrinology unit with a diagnosis of primary amenorrhea, history of Growth Hormone deficiency and multiple congenital anomalies including rectal atresia. The subsequent hormonal investigation led to the diagnosis of hypogonadotropic hypogonadism and persistent GH deficiency. Abdominal and pelvic ultrasounds were normal whereas the brain MRI revealed a hypoplastic sella turcica with a hypoplastic anterior pituitary lobe, an ectopic posterior pituitary lobe and a thin pituitary stalk. The genetic analysis revealed a novel pathogenic missense heterozygous variant (c.1958G > A, p.Agr635Gln) in exon 15 of FGFR1 gene. PubMed, Scopus, and Web of Science were searched for the identification of studies reporting cases of CPHD with FGFR1 gene defects.
Of the 648 records retrieved, 10 were included in this review. A comprehensive overview of the cases was summarized, and their clinical and genetic characteristics were presented.
Although FGFR1 variants have been associated with Kallmann syndrome and isolated hypogonadotropic hypogonadism and recently with CPHD, the patient's phenotype includes phenotypic alterations not previously described, to the best of our knowledge, within the spectrum of non-reproductive features of either of these entities. Isolated GH deficiency combined with other non-common abnormalities exerts a great possibility for subsequent CPHD manifestation.
报告一例合并垂体激素缺乏症(CPHD)和成纤维细胞生长因子受体1(FGFR1)基因缺陷的病例,并通过回顾文献中的现有报告总结类似病例的临床特征。
一名24岁女性因原发性闭经、生长激素缺乏病史以及包括直肠闭锁在内的多种先天性畸形入住门诊内分泌科。随后的激素检查诊断为低促性腺激素性性腺功能减退和持续性生长激素缺乏。腹部和盆腔超声检查正常,而脑部MRI显示蝶鞍发育不全,垂体前叶发育不全,垂体后叶异位,垂体柄纤细。基因分析显示FGFR1基因第15外显子存在一种新的致病性错义杂合变异(c.1958G>A,p.Agr635Gln)。检索了PubMed、Scopus和Web of Science以查找报告CPHD合并FGFR1基因缺陷病例的研究。
在检索到的648条记录中,本综述纳入了10条。总结了病例的全面概况,并呈现了它们的临床和基因特征。
尽管FGFR1变异与卡尔曼综合征、孤立性低促性腺激素性性腺功能减退有关,最近还与CPHD有关,但据我们所知,患者的表型包括这些实体的非生殖特征范围内以前未描述过的表型改变。孤立性生长激素缺乏合并其他不常见异常很可能随后出现CPHD表现。